We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Dealbreaker?

10 December 2013 By Olaf Storbeck

The hedge fund has amassed enough votes to block McKesson’s $8 bln takeover bid. The U.S. offer for the German drug wholesaler does look a bit stingy. But Elliott will suffer if the deal fails – so McKesson can probably hold firm. Elliott has other ways to make money here.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)